Skip to content
Back to CGEM

Cullinan Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
29
Purchases
0
Sales
29
Purchase value
$0.00
Sale value
$2.46M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 5, 20260001193125-26-452004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF14,000$12.36$49.44K158,649Direct
Filing footnotes · 2
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F225% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Sep 10, 2026Period of report Sep 8, 20260001193125-26-387381
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Common StockF1F28,000$21.57$172.56K158,844Direct
Filing footnotes · 3
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.31 to $21.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F325% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Aug 14, 2026Period of report Aug 13, 20260001193125-26-352523
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 13, 2026
Common StockF1F230,000$20.26$607.80K162,844Direct
Filing footnotes · 3
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F325% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 6, 20260001193125-26-297605
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF1F28,000$17.82$142.56K162,844Direct
Filing footnotes · 3
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.35 to $18.19. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F325% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed May 6, 2026Period of report May 5, 20260001193125-26-209307
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 5, 2026
Common StockF1F27,800$14.60$113.88K167,044Direct
SaleMay 5, 2026
Common StockF1F3200$15.58$3.12K166,844Direct
Filing footnotes · 4
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.24 to $15.12. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.56 to $15.60. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F425% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Mar 9, 2026Period of report Mar 5, 20260001193125-26-098781
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 5, 2026
Common StockF1F28,000$15.68$125.44K170,844Direct
Filing footnotes · 3
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.38 to $16.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F325% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 25, 20260001193125-26-077259
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 25, 2026
Common StockF1F21,780$14.14$25.17K174,844Direct
Filing footnotes · 2
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.89 to $14.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Feb 25, 2026Period of report Feb 23, 20260001193125-26-072002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF33,601$14.47$52.11K176,624Direct
SaleFeb 23, 2026
Common StockF1F21,752$13.99$24.51K180,225Direct
Filing footnotes · 3
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.68 to $14.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Nadim AhmedDirector · President and CEO
4
Filed Feb 25, 2026Period of report Feb 24, 20260001193125-26-072001
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF113,515$14.47$195.56K390,803Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jeffrey Alan JonesChief Medical Officer
4
Filed Feb 25, 2026Period of report Feb 24, 20260001193125-26-072000
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF14,582$14.47$66.30K159,968Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jacquelyn L SumerChief Legal Officer
4
Filed Feb 25, 2026Period of report Feb 24, 20260001193125-26-071997
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF13,601$14.47$52.11K128,089Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Mary Kay FentonChief Financial Officer
4
Filed Feb 23, 2026Period of report Feb 20, 20260001193125-26-064261
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF14,398$13.62$59.90K126,380Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jeffrey Alan JonesChief Medical Officer
4
Filed Feb 23, 2026Period of report Feb 20, 20260001193125-26-064257
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF14,982$13.62$67.85K164,550Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Feb 23, 2026Period of report Feb 20, 20260001193125-26-064256
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF13,742$13.62$50.97K181,977Direct
SaleFeb 20, 2026
Common StockF28,000$14.30$114.40K181,977Direct
Filing footnotes · 3
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
  2. F2Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  3. F325% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jacquelyn L SumerChief Legal Officer
4
Filed Feb 23, 2026Period of report Feb 20, 20260001193125-26-064255
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF13,742$13.62$50.97K131,690Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Nadim AhmedDirector · President and CEO
4
Filed Feb 23, 2026Period of report Feb 20, 20260001193125-26-064254
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 20, 2026
Common StockF116,381$13.62$223.11K404,318Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4
Filed Feb 13, 2026Period of report Feb 12, 20260001193125-26-051700
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 12, 2026
Common StockF1416$12.03$5.00K128,219Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Jan 23, 2026Period of report Jan 22, 20260001193125-26-021225
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF14,000$12.30$49.20K128,635Direct
Filing footnotes · 1
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
Open on SEC EDGAR
Nadim AhmedDirector · President and CEO
4
Filed Dec 29, 2025Period of report Dec 23, 20250001193125-25-335482
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 23, 2025
Common StockF19,922$10.01$99.32K420,699Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Dec 22, 2025Period of report Dec 19, 20250001193125-25-328909
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 19, 2025
Common StockF1F21,345$10.01$13.46K132,635Direct
Filing footnotes · 2
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.99 to $10.09. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Jacquelyn L SumerChief Legal Officer
4
Filed Dec 19, 2025Period of report Dec 18, 20250001193125-25-327033
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF1F23,480$9.67$33.65K135,432Direct
Filing footnotes · 2
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
  2. F2Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open on SEC EDGAR
Jeffrey Alan JonesChief Medical Officer
4
Filed Dec 19, 2025Period of report Dec 18, 20250001193125-25-327030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF14,632$9.67$44.79K169,532Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4
Filed Dec 19, 2025Period of report Dec 18, 20250001193125-25-327027
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF12,898$9.67$28.02K133,980Direct
Filing footnotes · 1
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 12, 20250001193125-25-321122
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 15, 2025
Common StockF3995$11.90$11.84K136,878Direct
SaleDec 12, 2025
Common StockF1F22,148$12.38$26.59K137,873Direct
Filing footnotes · 3
  1. F1Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
  2. F2Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  3. F3Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
Open on SEC EDGAR
Jennifer MichaelsonChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Nov 25, 2025Period of report Nov 24, 20250001193125-25-297549
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 24, 2025
Common StockF14,000$12.30$49.20K138,004Direct
Filing footnotes · 1
  1. F1Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.